![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Tela Bio Picks New Clinical Development Executive
Tela Bio Picks New Clinical Development Executive
Pennsylvania-based bioscaffold developer Tela Bio has appointed Bruce Freedman as its new vice president of clinical development.
The company, which focuses on medical technologies for soft-tissue reconstruction, chose Freedman based on his 32 years of experience as a general surgeon specializing in hernia repair and abdominal wall reconstruction, including with the company’s OviTex reinforced-tissue surgical mesh.
In his new role, Freedman will act as an advocate for the company’s natural hernia-repair mesh as an alternative to permanent and resorbable synthetic mesh.
Upcoming Events
-
21Oct